CD39 and CD73 expressed on ovarian cancer cells generate adenosine that exerts an immunosuppressive effect, which was relieved by siRNAs against CD39 and CD73 and by an A2A antagonist [444]. The gene discussed is ENTPD1; the disease is ovarian cancer.